Related Experiment Videos
JunB inhibits proliferation and transformation in B-lymphoid cells
Agnieszka P Szremska1, Lukas Kenner, Eva Weisz
1Department of Pharmacology, Vienna University, Währingerstrasse 13A, A-1090 Vienna, Austria.
Blood
|August 9, 2003
Summary
JunB, a protein involved in cell regulation, acts as a negative regulator in B-cell development and transformation. Overexpression of JunB inhibits B-cell proliferation and oncogenesis, though cancer cells can eventually overcome this effect.
Area of Science:
- Molecular Biology
- Immunology
- Oncology
Background:
- Activating Protein 1 (AP-1) family member JunB is implicated in leukemogenesis.
- JunB expression varies across lymphoma types, being high in T-cell lymphomas but low in B-cell lymphomas.
Purpose of the Study:
- To investigate the role of JunB as a negative regulator of B-cell development, proliferation, and transformation.
- To understand the impact of JunB on B-cell susceptibility to oncogenes.
Main Methods:
- Surveyed human lymphoma samples for AP-1 member expression.
- Utilized JunB transgenic mice with elevated JunB levels in lymphoid cells.
- Assessed B-lymphoid cell responses to mitogenic stimuli and oncogene transformation in vitro and in vivo.
Main Results:
- JunB transgenic B-lymphoid cells showed reduced response to mitogens and lower susceptibility to Abelson oncogene transformation.
- Overexpression of JunB provided partial protection against oncogenic challenge in vivo.
- Transformed B cells from JunB transgenic mice eventually escaped inhibitory effects, showing similar proliferation to controls.
Conclusions:
- JunB acts as a novel negative regulator of B-cell proliferation and transformation.
- JunB's inhibitory effects on B-cell transformation can be overcome by acquired resistance mechanisms.